Eyal Dor-On

Eyal Dor-On is an accomplished professional in the field of biology and oncology, currently serving as the Director of Biology and Head of Biology at Novocure since March 2020, where responsibilities include leading research in innovative cancer treatments utilizing electric fields. Prior to this role, Eyal held the position of Senior Scientist at Vidac Pharma from March 2017 to March 2019, managing interdisciplinary research projects focused on oncologic and dermatologic diseases. Eyal's earlier experience includes a postdoctoral fellowship and laboratory management at Tel Aviv University, working under Dr. Chen Luxenburg, and a research associate position in Professor Beka Solomon's group, concentrating on drug delivery methods for treating malignancies. Eyal has a robust educational background, holding a PhD in Molecular Microbiology and Biotechnology, an MS in Cell Biology and Immunology, and a BS in Biology, all from Tel Aviv University.